IBO

Impact BioMedical Inc.$0.54+0.05 (+10.89%)

Prev Close$0.48·MCap$8.3M·P/E—·Vol115.6K·Yield—

▲

Buys (12M)

$0.00

▼

Sells (12M)

$145.8K

◆

Net Activity

Net Seller

$145.8K

●

Active Insiders

last 12 mo

Over the past 12 months, insider activity at Impact BioMedical Inc. (IBO) has been exclusively selling, with 0 insider purchases totaling $0.00 and 3 insider sales totaling $145.8K. The most recent insider transaction was by Macko Todd D (officer: Chief Financial Officer), who sold $25.3K worth of shares on Mar 30, 2026. Impact BioMedical Inc. operates in the Healthcare sector, within the Biotechnology industry, with a market cap of $8.3M.

IBO Insider Trading Activity

Date	Insider	Role	Type	Shares	Avg Price	Value	Shares After
Mar 30, 2026	Macko Todd D	officer: Chief Financial Officer	Sell	45,000	$0.56	$25.3K	198,122
Mar 25, 2026	Grady Jason	director	Sell	50,000	$0.65	$32.5K	250,182
Jan 6, 2026	DSS, INC.	10 percent owner	Sell	161,000	$0.55	$88.0K1.3% OS	590,424
Apr 3, 2025	Chan Heng Fai Ambrose	Director	Sell	351,555	$0.50	$174.0K2.8% OS	0
Apr 2, 2025	Chan Heng Fai Ambrose	Director	Sell	2,526,918	$1.15	$2.91M20.2% OS	1,910,976-57%
Mar 28, 2025	DSS, INC.	10% Owner	Sell	272,420	$3.12	$851.2K2.2% OS	1,109,339
Mar 24, 2025	DSS, INC.	10% Owner	Buy	200	$1.55	$310.00	53,280
Mar 24, 2025	DSS, INC.	10% Owner	Sell	53,300	$4.68	$249.4K	53,080-50%
Dec 9, 2024	Heuszel Frank D	Chief Executive Officer	Buy	500	$2.26	$1.1K	97,344
Dec 3, 2024	Heuszel Frank D	Chief Executive Officer	Buy	1,550	$2.61	$4.0K	96,844

IBO Insider Buying Activity

The following table shows recent insider purchases of Impact BioMedical Inc. (IBO) stock reported via SEC Form 4 filings.

Date	Insider	Role	Type	Shares	Avg Price	Value	Shares After
Mar 24, 2025	DSS, INC.	10% Owner	Buy	200	$1.55	$310.00	53,280
Dec 9, 2024	Heuszel Frank D	Chief Executive Officer	Buy	500	$2.26	$1.1K	97,344
Dec 3, 2024	Heuszel Frank D	Chief Executive Officer	Buy	1,550	$2.61	$4.0K	96,844

IBO Insider Selling Activity

The following table shows recent insider sales of Impact BioMedical Inc. (IBO) stock reported via SEC Form 4 filings.

Date	Insider	Role	Type	Shares	Avg Price	Value	Shares After
Mar 30, 2026	Macko Todd D	officer: Chief Financial Officer	Sell	45,000	$0.56	$25.3K	198,122
Mar 25, 2026	Grady Jason	director	Sell	50,000	$0.65	$32.5K	250,182
Jan 6, 2026	DSS, INC.	10 percent owner	Sell	161,000	$0.55	$88.0K1.3% OS	590,424
Apr 3, 2025	Chan Heng Fai Ambrose	Director	Sell	351,555	$0.50	$174.0K2.8% OS	0
Apr 2, 2025	Chan Heng Fai Ambrose	Director	Sell	2,526,918	$1.15	$2.91M20.2% OS	1,910,976-57%
Mar 28, 2025	DSS, INC.	10% Owner	Sell	272,420	$3.12	$851.2K2.2% OS	1,109,339
Mar 24, 2025	DSS, INC.	10% Owner	Sell	53,300	$4.68	$249.4K	53,080-50%